
Targeting synapse loss – Clinical evidence for a new approach in early Alzheimer's disease
Chair introduction
Strategies for managing early AD
Hilkka Soininen, Finland
Management of AD: Where do we stand?
Ian McKeith, UK
Introducing a new concept in AD, targeting synapse loss
Patrick Kamphuis, the Netherlands
The Souvenaid clinical trial programme: What have we learnt?
Christine von Arnim, Germany
A satellite symposium sponsored by Nutricia
Short Communications session 3: Ageing and Dementia
A randomized, double-blind, placebocontrolled clinical trial of intravenous bapineuzumab in patients with Alzheimer's disease who are apolipoprotein E ε4 carriers
Speaker: Reisa Sperling
Sperling_Bapineuzumab IV Study 302_EFNS Presentation Slides_9-11-2012.pdf
A randomized, double-blind, placebocontrolled clinical trial of intravenous bapineuzumab in patients with Alzheimer's disease who are apolipoprotein E ε4 non-carriers
Speaker: Steven Salloway
Salloway_Bapineuzumab IV Study 301_EFNS Presentation Slides_9-11-2012.pdf
Production of the webcast was funded by the Alzheimer’s Immunotherapy Program of Janssen Alzheimer Immunotherapy and Pfizer Inc.
Sessions available upon purchase
Clicking the links will take you to the webstore to purchase the access.
The BUY ALL package includes all of the below mentioned.
Sessions only included in the BUY ALL package:
|
TC |
Challenging acute headache disorders |
|
TC |
Clinical assessment of the vestibular system |
|
TC |
Hands-on course on clinical neurophysiology |
|
TC |
Hands-on course on neurosonology |
|
TC |
Management of sleep disorders in neurological diseases |
|
TC |
Neurocritical care |
|
TC |
Novel treatment options in neuropathic pain |
|
MT |
Genes and environment in migraine |
|
MT |
Hot-spots in neuro-oncology |
|
FW |
Autoimmune encephalitis – clinical and immunological aspects |
|
FW |
Diagnosis and therapy of myasthenic syndromes |
|
FW |
Drugs in the pipeline for migraine |
|
FW |
Imaging in pain |
|
FW |
Synaesthesia: the neural plasticity of perception |
TRACK 1 - CEREBROVASCULAR DISEASE
|
TC |
Update on intracerebral haemorrhage - basic clinical knowledge |
|
TC |
New aspects on stroke in the young - advanced |
|
MT |
Stroke and hypertension - new insights, new challenges |
|
FW |
Epidemiological disparities affecting the management of stroke patients |
|
FW |
The role of neuroinflammation / microglia activation in ischemic stroke |
TRACK 2 - MOVEMENT DISORDERS
|
TC |
Movement disorders – basic clinical knowledge |
|
TC |
Movement disorders – advanced |
|
MT |
EFNS/ENS main topic: Therapeutic challenges in neuromuscular disorders |
|
MT |
Hot topics in movement disorders |
|
FW |
Outcome measures in neuromuscular disorders: from its basic aspects to its modern approach |
|
FW |
Update on tremor |
|
SS |
The Movement Disorder Society European Basal Ganglia Club |
TRACK 3 - EPILEPSY AND RELATED DISORDERS
|
TC |
Clinical skills and ancillary studies in the diagnosis of epilepsy – basic clinical knowledge |
|
TC |
Recognition of epilepsy syndromes. Why does it matter? - advanced |
|
TC |
Seizure – syncope – or something else? |
|
MT |
Stimulation and implantation therapies for epilepsy |
|
FW |
Autonomic alterations in epilepsy |
|
SS |
EFNS-ILAE-CEA Joint Session: Treatment of epilepsies |
TRACK 4 - ALZHEIMER'S AND DEMENTIA
|
TC |
Luigi Amaducci teaching course on dementia: the basics of dementia; diagnosis and treatment – basic clinical knowledge |
|
TC |
Luigi Amaducci teaching course on dementia: update on the latest advances in diagnosis and therapy – advanced |
|
MT |
Current and future management of dementia |
|
FW |
Update on tauopathies |
TRACK 5 - DEMYELINATING DISORDERS; MULTIPLE SCLEROSIS AND RELATED DISORDERS
|
TC |
Immune-mediated demyelinating neuropathies: clinical presentations, pathophysiology, diagnosis and treatment |
|
TC |
Multiple sclerosis pathogenesis and epidemiology - advanced |
|
TC |
Multiple sclerosis work-up – basic clinical knowledge |
|
MT |
Therapeutic advances in multiple sclerosis |
|
FW |
Amyotrophic lateral sclerosis – the multiple aetiological factors |
|
FW |
Emerging concepts for the work-up of neuromyelitis optica (NMO) spectrum disorders |
|
SS |
Joint Session EFNS – Mediterranean Neurological Societies: Demyelinating disorders |
GENERAL SESSIONS - Included in any of the above packages
|
TC |
Basics on scientific publishing |
|
TC |
How do I examine…? |
|
TC |
My most controversial cases |
|
TC |
Therapy in neurology I |
|
TC |
Therapy in neurology II |
|
MT |
Autonomic disorders in neurological diseases |
|
MT |
Controversies in neurology |
|
MT |
Emerging infections of the central nervous system |
|
MT |
Monitoring treatment effects in neurological disorders: the role of neuroimaging techniques |
|
FW |
Social neuroscience: clinical implications |
|
FW |
State-of-the-art treatment in neurology: EFNS Scientist Panels’ recommendations |
|
SS |
Burden of neurological diseases |
|
SS |
Critical illness and end-of-life considerations |
|
SS |
EAYNT Session: European harmonisation of neurology education |
|
SS |
EFNS-EFNA Awareness Session |
|
SS |
EFNS Lecture on Clinical Neurology |
|
SS |
Highlights of the Congress and latest news |
|
SS |
How to address the sympathetic dysfunction |